EDGAR Filing Documents for 0001493152-22-026321

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

SEC Accession No. 0001493152-22-026321

Filing Date

2022-09-20

Accepted

2022-09-20 09:22:06

Documents

Period of Report

2021-07-27

Document Format Files

Seq	Description	Document	Type	Size
1		ownership.html	4/A
1		ownership.xml	4/A	5397
	Complete submission text file	0001493152-22-026321.txt		7304

Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477

Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333

IRS No.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ROBERT S. LEVIN, ESQ., TRUSTEE 180 NORTH LASALLE STREET, SUITE 3200 CHICAGO IL 60601

Business Address C/O ROBERT S. LEVIN, ESQ., TRUSTEE 180 NORTH LASALLE STREET, SUITE 3200 CHICAGO IL 60601 312-368-0100

Francisco Trust under agreement dated February 28, 1996 (Reporting) CIK: 0001328329 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 001-32513 | Film No.: 221252191